Poly Medicure Limited Share Price NSE India S.E.
Equities
POLYMED
INE205C01021
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,453.10 INR | -0.63% |
|
+8.91% | -18.08% |
| 09/02 | IIFL Downgrades Poly Medicure to Reduce from Add; Price Target is INR1,230 | MT |
| 07/02 | Poly Medicure Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
| Capitalization | 15TCr 157.21Cr 134.31Cr 123.84Cr 116.86Cr 217.17Cr 222.68Cr 1.45TCr 570.25Cr 7.03TCr 590Cr 577.49Cr 25TCr | P/E ratio 2026 * |
42.2x | P/E ratio 2027 * | 37.8x |
|---|---|---|---|---|---|
| Enterprise value | 14TCr 145.46Cr 124.27Cr 114.58Cr 108.13Cr 200.93Cr 206.03Cr 1.34TCr 527.62Cr 6.5TCr 545.89Cr 534.32Cr 23TCr | EV / Sales 2026 * |
7.27x | EV / Sales 2027 * | 5.99x |
| Free-Float |
32.64% | Yield 2026 * |
0.33% | Yield 2027 * | 0.36% |
Last Transcript: Poly Medicure Limited
| 1 day | -0.63% | ||
| 1 week | +8.91% | ||
| Current month | +22.00% | ||
| 1 month | +10.73% | ||
| 3 months | -17.07% | ||
| 6 months | -23.36% | ||
| Current year | -18.08% |
| 1 week | 1,346.2 |  | 1,478 |
| 1 month | 1,182 | | 1,478 |
| Current year | 1,182 | | 1,839 |
| 1 year | 1,182 | | 2,937.6 |
| 3 years | 921.1 | | 3,357.8 |
| 5 years | 651.1 | | 3,357.8 |
| 10 years | 130.65 | | 3,357.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Himanshu Baid
CEO | Chief Executive Officer | 57 | 13/01/2010 |
| Director of Finance/CFO | - | 01/07/2021 | |
| Chief Operating Officer | 58 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 88 | 26/05/2005 | |
| Director/Board Member | 84 | 13/01/2010 | |
Rishi Baid
BRD | Director/Board Member | 53 | 30/03/1995 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.63% | +8.91% | - | - | 159.35Cr | |
| +0.11% | -1.99% | -21.65% | -3.23% | 17TCr | |
| +0.44% | +1.46% | +3.94% | +7.29% | 11TCr | |
| -0.76% | -1.14% | +11.69% | +89.69% | 6.24TCr | |
| -1.09% | +5.78% | +95.77% | +105.13% | 6.22TCr | |
| +0.38% | -0.53% | -24.90% | -39.72% | 4.39TCr | |
| +2.63% | +5.88% | - | - | 3.7TCr | |
| -2.55% | -1.03% | -7.17% | -46.20% | 2.46TCr | |
| +0.21% | +1.31% | -0.52% | +14.21% | 2.18TCr | |
| -0.23% | -2.20% | -20.30% | +12.40% | 1.98TCr | |
| Average | -0.19% | +1.04% | +4.61% | +17.45% | 6.21TCr | |
| Weighted average by Cap. | -0.01% | +0.30% | +3.18% | +19.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.87TCr 20Cr 17Cr 16Cr 15Cr 28Cr 28Cr 184.58Cr 73Cr 894.62Cr 75Cr 73Cr 3.2TCr | 2.26TCr 24Cr 21Cr 19Cr 18Cr 33Cr 34Cr 222.51Cr 87Cr 1.08TCr 91Cr 89Cr 3.85TCr |
| Net income | 349.07Cr 3.73Cr 3.18Cr 2.94Cr 2.77Cr 5.15Cr 5.28Cr 34Cr 14Cr 166.7Cr 14Cr 14Cr 595.48Cr | 391.34Cr 4.18Cr 3.57Cr 3.29Cr 3.11Cr 5.77Cr 5.92Cr 39Cr 15Cr 186.89Cr 16Cr 15Cr 667.59Cr |
| Net Debt | -1.1TCr -12Cr -10Cr -9.26Cr -8.74Cr -16Cr -17Cr -108.43Cr -43Cr -525.56Cr -44Cr -43Cr -1.88TCr | -1.19TCr -13Cr -11Cr -10Cr -9.45Cr -18Cr -18Cr -117.31Cr -46Cr -568.59Cr -48Cr -47Cr -2.03TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 1,453.10 ₹ | -0.63% | 63,434 |
| 10/26/10 | 1,462.30 ₹ | +1.63% | 99,477 |
| 09/26/09 | 1,438.80 ₹ | -0.11% | 1,00,453 |
| 08/26/08 | 1,440.40 ₹ | +3.63% | 1,74,903 |
| 07/26/07 | 1,390.00 ₹ | +1.45% | 1,36,708 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- POLYMED Stock
- POLYMED Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition